JAK inhibitors containing a 4-membered heterocyclic amide Grant US-11878977-B2 United States of America 23 Jan 2024
Ester and carbonate pyrimidine compounds as JAK kinase inhibitors Grant US-11845747-B2 United States of America 19 Dec 2023
Pyrimidine compound as JAK kinase inhibitor Grant US-11814377-B2 United States of America 14 Nov 2023
Methods of treatment using a JAK inhibitor compound Grant US-11786517-B2 United States of America 17 Oct 2023
5 to 7 membered heterocyclic amides as JAK inhibitors Grant US-11713315-B2 United States of America 01 Aug 2023
Crystalline hydrate of a JAK inhibitor compound Grant US-11702415-B2 United States of America 18 Jul 2023
Fused pyrimidine pyridinone compounds as JAK inhibitors Grant US-11697648-B2 United States of America 11 Jul 2023
Dimethyl amino azetidine amides as JAK inhibitors Grant US-11634419-B2 United States of America 25 Apr 2023
Administration of gut-selective JAK3 inhibitor Grant US-11471442-B2 United States of America 18 Oct 2022
JAK inhibitors containing a 4-membered heterocyclic amide Grant US-11453668-B2 United States of America 27 Sep 2022
Pyrimidine JAK inhibitors for the treatment of skin diseases Grant US-11439641-B2 United States of America 13 Sep 2022
Pyrimidine compound as JAK kinase inhibitor Grant US-11420965-B2 United States of America 23 Aug 2022
Imidazole and triazole containing bicyclic compounds as JAK inhibitors Grant US-11339160-B2 United States of America 24 May 2022
Fused imidazo-piperidine JAK inhibitor compound Grant US-11160810-B2 United States of America 02 Nov 2021
Methods of treatment using a JAK inhibitor compound Grant US-11160800-B2 United States of America 02 Nov 2021
Ester and carbonate pyrimidine compounds as JAK kinase inhibitors Grant US-11155549-B2 United States of America 26 Oct 2021
Pyrimidine compound as JAK kinase inhibitor Grant US-10988470-B2 United States of America 27 Apr 2021
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors Grant US-10968205-B2 United States of America 06 Apr 2021
JAK inhibitors containing a 4-membered heterocyclic amide Grant US-10954237-B2 United States of America 23 Mar 2021
Dimethyl amino azetidine amides as JAK inhibitors Grant US-10947229-B2 United States of America 16 Mar 2021
CLOZAPINE FOR USE IN TREATING PATHOGENIC IMMUNOGLOBULIN DRIVEN B CELL DISEASE Application WO-2021019249-A1 World Intellectual Property Organisation (WIPO) 04 Feb 2021
Imidazole and triazole containing bicyclic compounds as JAK inhibitors Grant US-10851102-B2 United States of America 01 Dec 2020
Process for preparing JAK inhibitors and intermediates thereof Grant US-10844057-B2 United States of America 24 Nov 2020
5 to 7 membered heterocyclic amides as JAK inhibitors Grant US-10836763-B2 United States of America 17 Nov 2020
Pyrimidine compound as JAK kinase inhibitor Grant US-10774080-B2 United States of America 15 Sep 2020
Pyrimidine compound as JAK kinase inhibitor Grant US-10562894-B2 United States of America 18 Feb 2020
Methods of treatment using a JAK inhibitor compound Grant US-10548886-B2 United States of America 04 Feb 2020
JAK inhibitors containing a 4-membered heterocyclic amide Grant US-10550118-B2 United States of America 04 Feb 2020
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors Application US-10538513-B2 United States of America 21 Jan 2020
Fused imidazo-piperidine JAK inhibitors Application US-10519153-B2 United States of America 31 Dec 2019
Fused imidazo-piperidine JAK inhibitor compound Grant US-10493077-B2 United States of America 03 Dec 2019
Methods of treatment using a JAK inhibitor compound Grant US-10406148-B2 United States of America 10 Sep 2019
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors Application US-10392368-B2 United States of America 27 Aug 2019
JAK inhibitors containing a 4-membered heterocyclic amide Grant US-10392386-B2 United States of America 27 Aug 2019
CLOZAPINE FOR THE TREATMENT OF IG-E DRIVEN B CELL DISEASES Application WO-2019149863-A1 World Intellectual Property Organisation (WIPO) 08 Aug 2019
Pyrimidine compound as JAK kinase inhibitor Application US-10308646-B2 United States of America 04 Jun 2019
Crystalline forms of a JAK inhibitor compound Application US-10251874-B2 United States of America 09 Apr 2019
Fused imidazo-piperidine JAK inhibitors Application US-10208040-B2 United States of America 19 Feb 2019
METHODS FOR TREATING ACTIVE EOSINOPHILIC ESOPHAGITIS Application WO-2019028367-A1 World Intellectual Property Organisation (WIPO) 07 Feb 2019
JAK inhibitors containing a 4-membered heterocyclic amide Application US-10196393-B2 United States of America 05 Feb 2019